Company · CIK 1774857
Aardvark Therapeutics, Inc.
| CIK | 1774857 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | AARD (Nasdaq) |
| First annual or quarterly report | 2025-03-31 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-294537 | 2026-03-23 | 2026-04-03 | 3 | |
| 333-284440 | 2025-01-23 | 2025-02-13 | 4 |
Filings
8| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-04-03 | EFFECTDeclared effective | 333-294537 | 9999999995-26-001083 |
| 2026-04-03 | 424B5Shelf takedown | 333-294537 | 0001193125-26-142105 |
| 2026-03-23 | S-3Shelf registered | 333-294537 | 0001193125-26-119973 |
| 2025-02-13 | 424B4Final prospectus | 333-284440 | 0001193125-25-026060 |
| 2025-02-12 | EFFECTDeclared effective | 333-284440 | 9999999995-25-000422 |
| 2025-02-06 | S-1/AAmendment | 333-284440 | 0001193125-25-021764 |
| 2025-01-23 | S-1Registration filed | 333-284440 | 0001193125-25-011499 |
| 2024-10-24 | DRSDraft made public | 377-07518 | 0000950123-24-009882 |